Abstract:The regioselective terminal hydroxylation of alkanes and fatty acids is of great interest in a variety of industrial applications, such as in cosmetics, in fine chemicals, and in the fragrance industry. The chemically challenging activation and oxidation of non-activated C-H bonds can be achieved with cytochrome P450 enzymes. CYP153AM.aq. -CPRBM3 is an artificial fusion construct consisting of the heme domain from Marinobacter aquaeolei and the reductase domain of CYP102A1 from Bacillus megaterium. It has the ability to hydroxylate medium- and long-chain fatty acids selectively at their terminal positions. However, the activity of this interesting P450 construct needs to be improved for applications in industrial processes. For this purpose, the design of mutant libraries including two consecutive steps of mutagenesis is demonstrated. Targeted positions and residues chosen for substitution were based on semi-rational protein design after creation of a homology model of the heme domain of CYP153AM.aq. , sequence alignments, and docking studies. Site-directed mutagenesis was the preferred method employed to address positions within the binding pocket, whereas diversity was created with the aid of a degenerate codon for amino acids located at the substrate entrance channel. Combining the successful variants led to the identification of a double variant-G307A/S233G-that showed alterations of one position within the binding pocket and one position located in the substrate access channel. This double variant showed twofold increased activity relative to the wild type for the terminal hydroxylation of medium-chain-length fatty acids. This variant furthermore showed improved activity towards short- and long-chain fatty acids and enhanced stability in the presence of higher concentrations of fatty acids.

Directed evolution of cytochrome P450DA hydroxylase activity for stereoselective biohydroxylation

Directed Evolution of P450 Fatty Acid Decarboxylases via High‐Throughput Screening towards Improved Catalytic Activity

Inverting the Enantioselectivity of P450pyr Monooxygenase by Directed Evolution.

Directed Evolution of Cytrochrome P450BM-3

Regiodivergent and Enantioselective Hydroxylation of C-H bonds by Synergistic Use of Protein Engineering and Exogenous Dual-Functional Small Molecules

CHAPTER 12. Controlling the Regio- and Stereoselectivity of Cytochrome P450 Monooxygenases by Protein Engineering

Enhanced Acylation Activity of Esterase BioH from Escherichia Coli by Directed Evolution Towards Improved Hydrolysis Activity

Improved Bioproduction of the Nylon 12 Monomer by Combining the Directed Evolution of P450 and Enhancing Heme Synthesis

Improving Hydrolytic Activity and Enantioselectivity of Epoxide Hydrolase from Phanerochaete chrysosporium by Directed Evolution

Semi-rational Directed Evolution in Improving Indole-Hydroxylation Ability of Cytochrome P450 BM-3

Biocatalytic Enantioselective Β‐hydroxylation of Unactivated C−H Bonds in Aliphatic Carboxylic Acids

Engineering P450 Monooxygenases for Highly Regioselective and Active p -Hydroxylation of m -Alkylphenols

Highly Enantioselective Hydroxylation of 3-Arylpropanenitriles to Access Chiral β-Hydroxy Nitriles by Engineering of P450pyr Monooxygenase

Molecular Basis for Chemoselectivity Control in Oxidations of Internal Aryl-Alkenes Catalyzed by Laboratory Evolved P450s

Improving the Activity of Cytochrome P450 BM-3 Catalyzing Indole Hydroxylation by Directed Evolution

Bacterial acyl homoserine lactones triggered non‐native substrate hydroxylation catalysed by directed‐evolution‐derived cytochrome P450BM3 mutants

A High-Throughput Visual Screen for the Directed Evolution of Cβ-stereoselectivity of L-threonine Aldolase

A High‐Throughput Visual Screen for the Directed Evolution of C β ‐stereoselectivity of L‐threonine Aldolase

Directed Evolution Enables Dynamic Control of Transient Intermediates for Anti-Markovnikov Wacker-Tsuji-Type Oxidation of Aliphatic Alkenes

Molecular Basis for Chemoselectivity Control in Oxidations of Internal Aryl‐Alkenes Catalyzed by Laboratory Evolved P450s

Semirational Protein Engineering of CYP153AM.aq. -CPRBM3 for Efficient Terminal Hydroxylation of Short- to Long-Chain Fatty Acids